(202) 681-7671
Knee Osteoarthritis Study Now Enrolling
Help advance regenerative medicine and explore new options for chronic knee pain.
ROSM, in collaboration with the Orthobiologics Research Institute (ORI), is now enrolling qualified participants in a new clinical study focused on knee osteoarthritis (OA).
If you’re living with chronic knee pain that hasn’t improved with physical therapy or medications, you may qualify for a new study exploring non-surgical, orthobiologic treatments for knee osteoarthritis.
This study aims to better understand how regenerative medicine can help patients delay or avoid major surgery — while improving joint function and quality of life.
Qualification Criteria
Diagnosis
Have symptomatic knee osteoarthritis (Kellgren-Lawrence grades 2–4)
Previous Treatment
Have tried at least 3 months of physical therapy or oral medications without lasting relief
Health Requirements
Do not have an autoimmune condition, active cancer, or systemic inflammatory condition such as rheumatoid arthritis
About ORI
The Orthobiologics Research Institute (ORI) is a non-profit organization dedicated to advancing research in regenerative medicine. ORI’s mission is to shift orthopedic medicine from reactive to preventative, helping patients avoid unnecessary surgery, expand treatment access, and reduce reliance on opioids.
Through collaboration with practices like ROSM, ORI leads clinical studies that help shape the future of orthobiologic treatments.
What to Expect
Participants in this study will:
1. Evaluation
Receive a comprehensive medical evaluation
2. Imaging
Undergo imaging to confirm eligibility
3. Guidance
ROSM physicians will inject treatment using ultrasound guidance.
4. Follow-Up
Receive follow-up assessments to track improvement in pain and function
Interested in joining the study?
Fill out the form below to schedule a screening consultation to see if you qualify.